4//SEC Filing
MCGLYNN MARGARET G 4
Accession 0000950170-24-027334
CIK 0001178879other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:21 PM ET
Size
12.9 KB
Accession
0000950170-24-027334
Insider Transaction Report
Form 4
MCGLYNN MARGARET G
Director
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2024-03-04−7,500→ 7,500 totalExercise: $2.80Exp: 2024-06-12→ Common Stock (7,500 underlying) - Exercise/Conversion
Stock Options (right to buy)
2024-03-05−7,500→ 0 totalExercise: $2.80Exp: 2024-06-12→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2024-03-04$2.80/sh+7,500$21,000→ 66,789 total - Exercise/Conversion
Common Stock
2024-03-05$2.80/sh+7,500$21,000→ 66,789 total - Sale
Common Stock
2024-03-05$13.40/sh−7,500$100,500→ 59,289 total - Sale
Common Stock
2024-03-04$13.29/sh−7,500$99,675→ 59,289 total
Footnotes (1)
- [F1]All of the options were fully vested and exercisable as of the transaction date.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001215126
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:21 PM ET
- Size
- 12.9 KB